The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release. The ...

A new position statement from the American Academy of Sleep Medicine (AASM) highlights sleepiness as a key symptom of sleep-wake disorders and a range of psychiatric and neurologic disorders and calls ...

DARIEN, IL — The American Academy of Sleep Medicine has released a new position statement emphasizing the clinical significance of sleepiness and its impact on performance, health, mood, safety, and ...

The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea. The Food and Drug Administration on Friday authorized the use of Zepbound, made by ...

Tired? Well, a new national survey shows that you're not alone. Researchers found that most adults feel sleepy during the day, and that tiredness affects many parts of everyday life. The American ...

A task force of experts commissioned by the American Academy of Sleep Medicine (AASM) have released updated recommendations for the treatment of central sleep apnea, published in the Journal of ...

The FDA also recommends that prescribed users reduce their caloric intake and increase their exercise Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide ...